• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核酸疫苗可在无反应小鼠中引发乙型肝炎病毒表面抗原特异性细胞毒性T淋巴细胞。

Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.

作者信息

Schirmbeck R, Böhm W, Ando K, Chisari F V, Reimann J

机构信息

Institute of Medical Microbiology, University of Ulm, Germany.

出版信息

J Virol. 1995 Oct;69(10):5929-34. doi: 10.1128/JVI.69.10.5929-5934.1995.

DOI:10.1128/JVI.69.10.5929-5934.1995
PMID:7666497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC189487/
Abstract

The efficiency of different vaccination techniques to prime in vivo major histocompatibility complex class I-restricted murine cytotoxic T-lymphocyte (CTL) precursors to hepatitis B virus small surface antigen (HBsAg) was investigated. Mice were immunized either by injection of a low dose of recombinant HBsAg protein preparations (native HBsAg particles or denatured HBsAg monomers) without adjuvants, by infection with recombinant vaccinia virus carrying an HBsAg-encoding gene, or by intramuscular transfer of plasmid DNA encoding HBsAg under appropriate promoter control. In H-2d mice, an Ld-restricted, S28-39-specific CTL response was efficiently primed by all alternative vaccination techniques tested, but the most potent priming of class I-restricted CTL to HBsAg in vivo was observed with DNA immunization. Priming of anti-HBsAg CTL in H-2b mice was not detectable after infection with a recombinant vaccinia virus or after injection with exogenous recombinant HBsAg preparations. After DNA immunization, however, both Kb- and Db-restricted CTL reactivity to HBsAg emerged in H-2b mice. Hence, nucleic acid immunization revealed class I-restricted CTL responsiveness to HBsAg in a mouse strain previously considered to be a nonresponder at the CTL level. These results demonstrate that the simple technique of nucleic acid immunization not only is extremely efficient but also reveals an extended spectrum of potentially immunogenic epitopes of protein antigens.

摘要

研究了不同疫苗接种技术在体内激发主要组织相容性复合体I类限制性小鼠细胞毒性T淋巴细胞(CTL)前体针对乙型肝炎病毒小表面抗原(HBsAg)的效率。小鼠通过以下方式免疫:注射低剂量无佐剂的重组HBsAg蛋白制剂(天然HBsAg颗粒或变性HBsAg单体);感染携带HBsAg编码基因的重组痘苗病毒;或在适当启动子控制下进行肌肉内转移编码HBsAg的质粒DNA。在H-2d小鼠中,所有测试的替代疫苗接种技术均能有效激发Ld限制性、S28-39特异性CTL反应,但在体内对HBsAg的I类限制性CTL的最有效激发是通过DNA免疫观察到的。在用重组痘苗病毒感染或注射外源性重组HBsAg制剂后,未检测到H-2b小鼠中抗HBsAg CTL的激发。然而,在DNA免疫后,H-2b小鼠中出现了对HBsAg的Kb和Db限制性CTL反应性。因此,核酸免疫揭示了在以前被认为在CTL水平上无反应的小鼠品系中对HBsAg的I类限制性CTL反应性。这些结果表明,核酸免疫的简单技术不仅极其有效,而且揭示了蛋白质抗原潜在免疫原性表位的扩展谱。

相似文献

1
Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.核酸疫苗可在无反应小鼠中引发乙型肝炎病毒表面抗原特异性细胞毒性T淋巴细胞。
J Virol. 1995 Oct;69(10):5929-34. doi: 10.1128/JVI.69.10.5929-5934.1995.
2
Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.启动针对外源性乙肝表面抗原的MHC-I限制性细胞毒性T淋巴细胞反应依赖于CD4 + T细胞。
J Immunol. 1999 Aug 15;163(4):1880-7.
3
Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen.
Intervirology. 1996;39(1-2):111-9. doi: 10.1159/000150482.
4
DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.乙肝表面抗原的DNA介导免疫。免疫反应的激活与调节。
Ann N Y Acad Sci. 1995 Nov 27;772:64-76. doi: 10.1111/j.1749-6632.1995.tb44732.x.
5
The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.针对乙型肝炎表面抗原(HBsAg)的免疫显性、Ld限制的T细胞应答可有效抑制T细胞对多种Dd、Kd和Kb限制的HBsAg表位的启动。
J Immunol. 2002 Jun 15;168(12):6253-62. doi: 10.4049/jimmunol.168.12.6253.
6
Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses.用重组痘苗病毒免疫C57BL/6小鼠后CTL反应的诱导及乙肝病毒表面抗原新表位的鉴定。
Virus Res. 2001 Jan;73(1):17-26. doi: 10.1016/s0168-1702(00)00219-7.
7
DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection.肌内注射后能在小鼠体内引发乙肝表面抗原特异性细胞毒性T淋巴细胞和抗体反应的DNA载体构建体。
J Immunol Methods. 1996 Jun 14;193(1):29-40. doi: 10.1016/0022-1759(96)00035-x.
8
Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells.增强基于外源性乙型肝炎表面抗原的疫苗对MHC-I限制性T细胞的免疫原性。
Biol Chem. 1999 Mar;380(3):285-91. doi: 10.1515/BC.1999.039.
9
Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis.小鼠对可溶性乙型肝炎病毒(HBV)S抗原的抗体和细胞毒性T细胞反应:对HBV诱导的肝炎发病机制的启示。
J Virol. 1994 Mar;68(3):1418-25. doi: 10.1128/JVI.68.3.1418-1425.1994.
10
Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.细菌CpG基序或白细胞介素-12对基因枪介导的针对乙型肝炎表面抗原的Th2免疫反应的调节作用
Intervirology. 2001;44(2-3):115-23. doi: 10.1159/000050038.

引用本文的文献

1
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.靶向固有和适应性免疫系统以治愈慢性乙型肝炎病毒感染的研究进展。
Front Immunol. 2020 Feb 7;10:3127. doi: 10.3389/fimmu.2019.03127. eCollection 2019.
2
Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling.氨基葡萄糖通过抑制自噬降解和抑制 MTORC1 信号通路的双重作用促进乙型肝炎病毒复制。
Autophagy. 2020 Mar;16(3):548-561. doi: 10.1080/15548627.2019.1632104. Epub 2019 Jun 23.
3
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives.癌症 DNA 疫苗:当前的临床前和临床进展及未来展望。
J Exp Clin Cancer Res. 2019 Apr 5;38(1):146. doi: 10.1186/s13046-019-1154-7.
4
Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.新型土拨鼠肝炎病毒 (WHV) 转基因小鼠模型显示出性别依赖性的 WHV 复制活性,并自发产生针对 WHV 蛋白的免疫反应。
J Virol. 2014 Feb;88(3):1573-81. doi: 10.1128/JVI.02086-13. Epub 2013 Nov 20.
5
Harnessing DNA-induced immune responses for improving cancer vaccines.利用 DNA 诱导的免疫反应来改进癌症疫苗。
Hum Vaccin Immunother. 2012 Nov 1;8(11):1682-93. doi: 10.4161/hv.22345. Epub 2012 Oct 30.
6
Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice.慢病毒载体表达 HBsAg 和免疫球蛋白 Fc 融合抗原可诱导强烈的免疫应答,并导致 HBsAg 转基因小鼠的血清转换。
Vaccine. 2011 May 17;29(22):3909-16. doi: 10.1016/j.vaccine.2011.03.025. Epub 2011 Mar 21.
7
A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection.DNA疫苗初免后用脂质体包裹的蛋白加强免疫可增强黏膜免疫反应并提供保护。
J Immunol. 2008 May 1;180(9):6159-67. doi: 10.4049/jimmunol.180.9.6159.
8
Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.乙肝表面抗原载体可将保护性细胞毒性T淋巴细胞反应传递给与疾病相关的外来表位。
J Virol. 2006 Apr;80(8):3975-84. doi: 10.1128/JVI.80.8.3975-3984.2006.
9
Pulmonary DNA vaccination: concepts, possibilities and perspectives.肺部DNA疫苗接种:概念、可能性与前景。
J Control Release. 2005 Sep 20;107(1):1-29. doi: 10.1016/j.jconrel.2005.05.028.
10
Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.用表达与细胞毒性T淋巴细胞相关抗原4融合的土拨鼠肝炎病毒核衣壳蛋白的基因进行免疫,可增强小鼠和土拨鼠的特异性免疫反应。
J Virol. 2005 May;79(10):6368-76. doi: 10.1128/JVI.79.10.6368-6376.2005.

本文引用的文献

1
Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression.体内将基因直接导入骨骼肌:影响转移效率和表达稳定性的因素。
Hum Gene Ther. 1993 Apr;4(2):151-9. doi: 10.1089/hum.1993.4.2-151.
2
Gene inoculation generates immune responses against human immunodeficiency virus type 1.基因接种可引发针对1型人类免疫缺陷病毒的免疫反应。
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4156-60. doi: 10.1073/pnas.90.9.4156.
3
The biochemistry and cell biology of antigen processing and presentation.抗原加工与呈递的生物化学和细胞生物学
Annu Rev Immunol. 1993;11:403-50. doi: 10.1146/annurev.iy.11.040193.002155.
4
Heterologous protection against influenza by injection of DNA encoding a viral protein.通过注射编码病毒蛋白的DNA实现对流感的异源保护。
Science. 1993 Mar 19;259(5102):1745-9. doi: 10.1126/science.8456302.
5
Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.用可溶性乙肝病毒表面蛋白进行免疫接种可在体内引发小鼠H-2 I类分子限制的CD8 +细胞毒性T淋巴细胞反应。
J Immunol. 1994 Feb 1;152(3):1110-9.
6
DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody.基于DNA的免疫接种可诱导乙肝表面抗原持续分泌及高水平循环抗体。
Hum Mol Genet. 1993 Nov;2(11):1847-51. doi: 10.1093/hmg/2.11.1847.
7
Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.I类限制性免疫病理学机制。暴发性肝炎的转基因小鼠模型。
J Exp Med. 1993 Nov 1;178(5):1541-54. doi: 10.1084/jem.178.5.1541.
8
Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.通过DNA疫苗接种实现对甲型流感的异源和同源保护:DNA载体的优化
DNA Cell Biol. 1993 Nov;12(9):777-83. doi: 10.1089/dna.1993.12.777.
9
Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle.在将基因直接导入成年小鼠骨骼肌方面,质粒DNA比病毒载体更具优势。
Hum Gene Ther. 1993 Dec;4(6):733-40. doi: 10.1089/hum.1993.4.6-733.
10
Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen.
Eur J Immunol. 1994 May;24(5):1088-96. doi: 10.1002/eji.1830240512.